Chordia Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is September - August.

Millions JPY. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 27, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023
Market Capitalization	11,428	12,418	51,534	-
Market Cap Growth	-35.31%	-75.90%	-	-
Enterprise Value	8,981	9,596	48,276	-
Last Close Price	155.00	180.00	780.00	-
PB Ratio	4.94	5.10	12.38	-
P/TBV Ratio	4.94	5.10	12.39	-
Net Debt / Equity Ratio	-1.06	-1.05	-1.04	-1.07
Net Debt / EBITDA Ratio	1.68	1.43	2.41	-22.00
Net Debt / FCF Ratio	1.83	1.38	2.23	-8.83
Quick Ratio	12.41	10.43	9.19	11.76
Current Ratio	12.68	10.92	9.78	11.98
Return on Equity (ROE)	-51.90%	-54.13%	-42.19%	-
Return on Assets (ROA)	-30.52%	-30.59%	-23.60%	-
Return on Capital Employed (ROCE)	-62.90%	-73.40%	-43.30%	4.70%
Earnings Yield	-12.63%	-14.38%	-3.55%	-
FCF Yield	-11.71%	-14.84%	-3.76%	-
Buyback Yield / Dilution	-8.20%	-16.82%	-4.05%	-

Updated Feb 28, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.